Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PFIZER

Pfizer, Inc. is the world’s largest pharmaceutical company in the world, by sales. The New York-based company produces the No. 1-selling drug, along with other widely used prescription drugs as Lipitor, Lyriuca, Diflucan, Celebrex and Viagra. This topic covers the latest news on Pfizer.

Pfizer is part of Business Exchange, suggested by Maki Yamasaki. This topic contains 1,236 news and 381 blog items. Read updated news, blogs, and resources about Pfizer. Find user-submitted articles and reactions on Pfizer from like-minded professionals.

News

Please add new articles to this topic

Pfizer's Application for Cancer Drug Accepted by FDAmore

Extract not available.

Neuronetics Gets 30M In VC Financingmore

$30 million of Series E financing. The deal was led by two new investors, Polaris Venture Partners and Pfizer Venture...

Bringing tax bucks back homemore

law. That roster -- including Apple (AAPL), Cisco (CSCO), Duke Energy (DUK), Google (GOOG), Kodak (EK), Microsoft...

Pfizer files Crizotinib new drug applicationsmore

LONDON (MarketWatch) -- Pfizer Inc. (NYSE:PFE

A Pfizer Break Up? That Would Be Somethingmore

the Pacific Research Institute. John R. Graham. Matthew Herper���s recent coverage of a potential break up of Pfizer is...

Pfizer Announces Simultaneous Filing Of New Drug Applications For Criz...more

Submission Accepted for Filing and Granted Priority Review by FDA NEW YORK, May 17, 2011 (BUSINESS WIRE) -- Pfizer Inc.

Roche and Merck tie up on hepatitis treatmentmore

Extract not available.

Pfizer Blames Teva, Ivax for ���Billions��� in Neurontin Lossesmore

(Updates with Pfizer arguments in fourth paragraph.) May 17 (Bloomberg) -- Pfizer Inc., the world���s biggest...

Drug-Resistant Germs Lure Biotechs to Lead Antibiotics Effortmore

antibiotics were a combined $6 billion in 2010, according to IMS Health Inc., a Norwalk, Connecticut-based research...

Pfizer's Anti-TNF-Alpha Nanobody (ATN-103) Successfully Completes a Ph...more

results from the recently completed POC Phase II clinical trial of ozoralizumab (ATN-103), an anti-TNF-alpha Nanobody...

Slow Turnover Rate for CEOsmore

Extract not available.

More Signs of Q2 Slowdown Hitting Stocks, Treasurysmore

Extract not available.

Pfizer To Present New Research From Fifteen Compounds Highlighting Mul...more

Pfizer Inc. will present more than 30 abstracts, including data from investigational compounds, axitinib, 1 crizotinib,...

Paulson discloses H-P position, sells Pfizermore

SAN FRANCISCO (MarketWatch) -- Paulson & Co.'s big investments in banks and gold were little changed during the...

Wall Street Stocks Close Lower in Late Tradingmore

iron ore pellets and metallurgical coal. Some health care stocks helped cushion the Dow industrials. The pharmaceutical...

Wall Street Stocks Head Lower in Late Tradingmore

produces iron ore pellets and metallurgical coal. Some health care stocks helped cushion the Dow industrials.

Neuronetics raises $30M for depression therapymore

by the Federal Drug Administration in 2008. Leading the latest fund-raising were life-science investors Polaris Venture...

Study success for Pfizer, Novartis drugsmore

Late-stage studies showed using Novartis' lung drug Onbrez Breezhaler alongside Pfizer's Spiriva HandiHaler gives...

Novartis Onbrez plus rival boosts lung functionmore

* Onbrez Breezhaler plus Pfizer drug help COPD patient * Duo better than taking only Pfizer's Spiriva Handihaler...

Shanghai Pharma prices HK shares at HK$23more

Holdings has agreed to subscribe to HK$300 million of shares and Malaysian conglomerate Guoco Group HK$150 million,...

2 Pharmaceutical Dividends to Buy and 1 to Avoidmore

growth rate of 11% coupled with its rapidly rising dividend makes this a dividend play you can trust. Pfizer (NYSE: PFE...

/ CORRECTION - Neuronetics, Inc. Raises $30 Million in Series E Financ...more

Venture Partners" rather than without the name as originally issued. Complete corrected text follows.

CORRECTED-Shanghai Pharma prices HK shares at HK$23more

Holdings has agreed to subscribe to $300 million of shares and Malaysian conglomerate Guoco Group $150 million, while...

11 Stocks to Watch: Dean Foods, Tycomore

Friday after Goldman Sachs raised the stock to buy from neutral. More on JNJ Investor Embraces Unloved Europe, Pfizer...

Investor Embraces Unloved Europe, Pfizermore

territory, says Norman Boersma, manager of the Templeton Growth Fund(TEPLX). His top picks include Telefonica(TEF) and...

Top Sources: Pfizer

  • blogs.barrons.com
  • BusinessWeek
  • knowledge.wharton.upenn.edu
  • online.wsj.com
  • MarketWatch
  • SeekingAlpha.com
  • TheStreet.com
  • Forbes.com
  • startribune.com
  • clinicaspace.com

Most Active Users in this Topic

see all contributors in Pfizer

Featured White Papers

Post a Job

Jobs in this Topic

NCBiotech Industrial Fellowship - Icagen, Inc. (Pfizer) North Carolina Biotechnology Center | Durham, NC
Posted: Apr 10
GM - Pfizer Nutrition Global Analytics Mindlance | Madison, NJ
Posted: May 26
Global Marketing Research Analyst - Pfizer Animal Health Pfizer | Madison, NJ
Posted: May 24
Pfizer-Summer Student Worker Program Kalamazoo, MI
Posted: May 20

Report comment contains invalid characters. ()
cancel
Search Cancel